$0.2800
-0.0186-6.23%
Last update: Nov 5, 4:20 PM
Heron Therapeutics Inc
HRTXNASDAQ
The average analyst price target for Heron Therapeutics is $6.50, 2244.9% above the current price. Of 4 analysts, 2 rate it Buy and 2 Hold. Targets range from $6 to $7. The latest change came on Aug 11, 2026, when HC Wainwright & Co. downgraded Heron Therapeutics from Buy to Neutral.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
